Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition

Borwin Bandelow, David Baldwin, Marianna Abelli, Blanca Bolea-Alamanac, Michel Bourin, Samuel R. Chamberlain, Eduardo Cinosi, Simon Davies, Katharina Domschke, Naomi Fineberg, Edna Grünblatt, Marek Jarema, Yong Ku Kim, Eduard Maron, Vasileios Masdrakis, Olya Mikova, David Nutt, Stefano Pallanti, Stefano Pini, Andreas StröhleFlorence Thibaut, Matilde M. Vaghi, Eunsoo Won, Dirk Wedekind, Adam Wichniak, Jade Woolley, Peter Zwanzger, Peter Riederer

Research output: Contribution to journalReview article

56 Citations (Scopus)

Abstract

Objective: Biomarkers are defined as anatomical, biochemical or physiological traits that are specific to certain disorders or syndromes. The objective of this paper is to summarise the current knowledge of biomarkers for anxiety disorders, obsessive-compulsive disorder (OCD) and posttraumatic stress disorder (PTSD). Methods: Findings in biomarker research were reviewed by a task force of international experts in the field, consisting of members of the World Federation of Societies for Biological Psychiatry Task Force on Biological Markers and of the European College of Neuropsychopharmacology Anxiety Disorders Research Network. Results: The present article (Part II) summarises findings on potential biomarkers in neurochemistry (neurotransmitters such as serotonin, norepinephrine, dopamine or GABA, neuropeptides such as cholecystokinin, neurokinins, atrial natriuretic peptide, or oxytocin, the HPA axis, neurotrophic factors such as NGF and BDNF, immunology and CO2 hypersensitivity), neurophysiology (EEG, heart rate variability) and neurocognition. The accompanying paper (Part I) focuses on neuroimaging and genetics. Conclusions: Although at present, none of the putative biomarkers is sufficient and specific as a diagnostic tool, an abundance of high quality research has accumulated that should improve our understanding of the neurobiological causes of anxiety disorders, OCD and PTSD.

Original languageEnglish
Pages (from-to)162-214
Number of pages53
JournalWorld Journal of Biological Psychiatry
Volume18
Issue number3
DOIs
Publication statusPublished - 2017 Apr 3

Fingerprint

Neurochemistry
Neurophysiology
Obsessive-Compulsive Disorder
Post-Traumatic Stress Disorders
Anxiety Disorders
Consensus
Biomarkers
Advisory Committees
Biological Psychiatry
Research
Cholecystokinin
Brain-Derived Neurotrophic Factor
Nerve Growth Factors
Atrial Natriuretic Factor
Nerve Growth Factor
Oxytocin
Allergy and Immunology
Neuropeptides
Neuroimaging
gamma-Aminobutyric Acid

Keywords

  • Anxiety disorders
  • genetic
  • neurobiology
  • neurochemistry
  • neuroimaging
  • review

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Biological markers for anxiety disorders, OCD and PTSD : A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition. / Bandelow, Borwin; Baldwin, David; Abelli, Marianna; Bolea-Alamanac, Blanca; Bourin, Michel; Chamberlain, Samuel R.; Cinosi, Eduardo; Davies, Simon; Domschke, Katharina; Fineberg, Naomi; Grünblatt, Edna; Jarema, Marek; Kim, Yong Ku; Maron, Eduard; Masdrakis, Vasileios; Mikova, Olya; Nutt, David; Pallanti, Stefano; Pini, Stefano; Ströhle, Andreas; Thibaut, Florence; Vaghi, Matilde M.; Won, Eunsoo; Wedekind, Dirk; Wichniak, Adam; Woolley, Jade; Zwanzger, Peter; Riederer, Peter.

In: World Journal of Biological Psychiatry, Vol. 18, No. 3, 03.04.2017, p. 162-214.

Research output: Contribution to journalReview article

Bandelow, B, Baldwin, D, Abelli, M, Bolea-Alamanac, B, Bourin, M, Chamberlain, SR, Cinosi, E, Davies, S, Domschke, K, Fineberg, N, Grünblatt, E, Jarema, M, Kim, YK, Maron, E, Masdrakis, V, Mikova, O, Nutt, D, Pallanti, S, Pini, S, Ströhle, A, Thibaut, F, Vaghi, MM, Won, E, Wedekind, D, Wichniak, A, Woolley, J, Zwanzger, P & Riederer, P 2017, 'Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition', World Journal of Biological Psychiatry, vol. 18, no. 3, pp. 162-214. https://doi.org/10.1080/15622975.2016.1190867
Bandelow, Borwin ; Baldwin, David ; Abelli, Marianna ; Bolea-Alamanac, Blanca ; Bourin, Michel ; Chamberlain, Samuel R. ; Cinosi, Eduardo ; Davies, Simon ; Domschke, Katharina ; Fineberg, Naomi ; Grünblatt, Edna ; Jarema, Marek ; Kim, Yong Ku ; Maron, Eduard ; Masdrakis, Vasileios ; Mikova, Olya ; Nutt, David ; Pallanti, Stefano ; Pini, Stefano ; Ströhle, Andreas ; Thibaut, Florence ; Vaghi, Matilde M. ; Won, Eunsoo ; Wedekind, Dirk ; Wichniak, Adam ; Woolley, Jade ; Zwanzger, Peter ; Riederer, Peter. / Biological markers for anxiety disorders, OCD and PTSD : A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition. In: World Journal of Biological Psychiatry. 2017 ; Vol. 18, No. 3. pp. 162-214.
@article{38995eb74dad4780a0b1f0fad99d8c5d,
title = "Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition",
abstract = "Objective: Biomarkers are defined as anatomical, biochemical or physiological traits that are specific to certain disorders or syndromes. The objective of this paper is to summarise the current knowledge of biomarkers for anxiety disorders, obsessive-compulsive disorder (OCD) and posttraumatic stress disorder (PTSD). Methods: Findings in biomarker research were reviewed by a task force of international experts in the field, consisting of members of the World Federation of Societies for Biological Psychiatry Task Force on Biological Markers and of the European College of Neuropsychopharmacology Anxiety Disorders Research Network. Results: The present article (Part II) summarises findings on potential biomarkers in neurochemistry (neurotransmitters such as serotonin, norepinephrine, dopamine or GABA, neuropeptides such as cholecystokinin, neurokinins, atrial natriuretic peptide, or oxytocin, the HPA axis, neurotrophic factors such as NGF and BDNF, immunology and CO2 hypersensitivity), neurophysiology (EEG, heart rate variability) and neurocognition. The accompanying paper (Part I) focuses on neuroimaging and genetics. Conclusions: Although at present, none of the putative biomarkers is sufficient and specific as a diagnostic tool, an abundance of high quality research has accumulated that should improve our understanding of the neurobiological causes of anxiety disorders, OCD and PTSD.",
keywords = "Anxiety disorders, genetic, neurobiology, neurochemistry, neuroimaging, review",
author = "Borwin Bandelow and David Baldwin and Marianna Abelli and Blanca Bolea-Alamanac and Michel Bourin and Chamberlain, {Samuel R.} and Eduardo Cinosi and Simon Davies and Katharina Domschke and Naomi Fineberg and Edna Gr{\"u}nblatt and Marek Jarema and Kim, {Yong Ku} and Eduard Maron and Vasileios Masdrakis and Olya Mikova and David Nutt and Stefano Pallanti and Stefano Pini and Andreas Str{\"o}hle and Florence Thibaut and Vaghi, {Matilde M.} and Eunsoo Won and Dirk Wedekind and Adam Wichniak and Jade Woolley and Peter Zwanzger and Peter Riederer",
year = "2017",
month = "4",
day = "3",
doi = "10.1080/15622975.2016.1190867",
language = "English",
volume = "18",
pages = "162--214",
journal = "World Journal of Biological Psychiatry",
issn = "1562-2975",
publisher = "Informa Healthcare",
number = "3",

}

TY - JOUR

T1 - Biological markers for anxiety disorders, OCD and PTSD

T2 - A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition

AU - Bandelow, Borwin

AU - Baldwin, David

AU - Abelli, Marianna

AU - Bolea-Alamanac, Blanca

AU - Bourin, Michel

AU - Chamberlain, Samuel R.

AU - Cinosi, Eduardo

AU - Davies, Simon

AU - Domschke, Katharina

AU - Fineberg, Naomi

AU - Grünblatt, Edna

AU - Jarema, Marek

AU - Kim, Yong Ku

AU - Maron, Eduard

AU - Masdrakis, Vasileios

AU - Mikova, Olya

AU - Nutt, David

AU - Pallanti, Stefano

AU - Pini, Stefano

AU - Ströhle, Andreas

AU - Thibaut, Florence

AU - Vaghi, Matilde M.

AU - Won, Eunsoo

AU - Wedekind, Dirk

AU - Wichniak, Adam

AU - Woolley, Jade

AU - Zwanzger, Peter

AU - Riederer, Peter

PY - 2017/4/3

Y1 - 2017/4/3

N2 - Objective: Biomarkers are defined as anatomical, biochemical or physiological traits that are specific to certain disorders or syndromes. The objective of this paper is to summarise the current knowledge of biomarkers for anxiety disorders, obsessive-compulsive disorder (OCD) and posttraumatic stress disorder (PTSD). Methods: Findings in biomarker research were reviewed by a task force of international experts in the field, consisting of members of the World Federation of Societies for Biological Psychiatry Task Force on Biological Markers and of the European College of Neuropsychopharmacology Anxiety Disorders Research Network. Results: The present article (Part II) summarises findings on potential biomarkers in neurochemistry (neurotransmitters such as serotonin, norepinephrine, dopamine or GABA, neuropeptides such as cholecystokinin, neurokinins, atrial natriuretic peptide, or oxytocin, the HPA axis, neurotrophic factors such as NGF and BDNF, immunology and CO2 hypersensitivity), neurophysiology (EEG, heart rate variability) and neurocognition. The accompanying paper (Part I) focuses on neuroimaging and genetics. Conclusions: Although at present, none of the putative biomarkers is sufficient and specific as a diagnostic tool, an abundance of high quality research has accumulated that should improve our understanding of the neurobiological causes of anxiety disorders, OCD and PTSD.

AB - Objective: Biomarkers are defined as anatomical, biochemical or physiological traits that are specific to certain disorders or syndromes. The objective of this paper is to summarise the current knowledge of biomarkers for anxiety disorders, obsessive-compulsive disorder (OCD) and posttraumatic stress disorder (PTSD). Methods: Findings in biomarker research were reviewed by a task force of international experts in the field, consisting of members of the World Federation of Societies for Biological Psychiatry Task Force on Biological Markers and of the European College of Neuropsychopharmacology Anxiety Disorders Research Network. Results: The present article (Part II) summarises findings on potential biomarkers in neurochemistry (neurotransmitters such as serotonin, norepinephrine, dopamine or GABA, neuropeptides such as cholecystokinin, neurokinins, atrial natriuretic peptide, or oxytocin, the HPA axis, neurotrophic factors such as NGF and BDNF, immunology and CO2 hypersensitivity), neurophysiology (EEG, heart rate variability) and neurocognition. The accompanying paper (Part I) focuses on neuroimaging and genetics. Conclusions: Although at present, none of the putative biomarkers is sufficient and specific as a diagnostic tool, an abundance of high quality research has accumulated that should improve our understanding of the neurobiological causes of anxiety disorders, OCD and PTSD.

KW - Anxiety disorders

KW - genetic

KW - neurobiology

KW - neurochemistry

KW - neuroimaging

KW - review

UR - http://www.scopus.com/inward/record.url?scp=84978483989&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978483989&partnerID=8YFLogxK

U2 - 10.1080/15622975.2016.1190867

DO - 10.1080/15622975.2016.1190867

M3 - Review article

C2 - 27419272

AN - SCOPUS:84978483989

VL - 18

SP - 162

EP - 214

JO - World Journal of Biological Psychiatry

JF - World Journal of Biological Psychiatry

SN - 1562-2975

IS - 3

ER -